Charles Reichman

1.2k total citations
16 papers, 797 citations indexed

About

Charles Reichman is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Charles Reichman has authored 16 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Genetics. Recurrent topics in Charles Reichman's work include Protein Kinase Regulation and GTPase Signaling (4 papers), Virus-based gene therapy research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Charles Reichman is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (4 papers), Virus-based gene therapy research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Charles Reichman collaborates with scholars based in United States. Charles Reichman's co-authors include Raymond B. Birge, Hidesaburô Hanafusa, J. Eduardo Fajardo, Zhou Songyang, Lewis C. Cantley, Bruce J. Mayer, Charalampos G. Kalodimos, Tamjeed Saleh, Satish Keshav and Steven E. Shoelson and has published in prestigious journals such as Molecular Cell, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Charles Reichman

16 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Reichman United States 11 547 261 196 145 120 16 797
Csilla A. Fenczik United States 8 579 1.1× 297 1.1× 199 1.0× 118 0.8× 126 1.1× 8 1.0k
Mary Rose Burnham United States 9 501 0.9× 399 1.5× 340 1.7× 95 0.7× 115 1.0× 12 849
Cynthia Seidel‐Dugan United States 16 977 1.8× 203 0.8× 221 1.1× 244 1.7× 252 2.1× 24 1.4k
Thorsten Erpel United States 6 409 0.7× 78 0.3× 112 0.6× 90 0.6× 79 0.7× 6 545
Behzad Aghazadeh United States 7 652 1.2× 107 0.4× 354 1.8× 75 0.5× 130 1.1× 8 892
A B Reynolds United States 8 994 1.8× 411 1.6× 567 2.9× 195 1.3× 123 1.0× 9 1.3k
Timothy J. Dudgeon United Kingdom 9 273 0.5× 196 0.8× 55 0.3× 77 0.5× 84 0.7× 10 469
Xiao-Jia Chang United States 7 680 1.2× 556 2.1× 264 1.3× 109 0.8× 371 3.1× 10 1.2k
Jian-Jiang Hao United States 14 364 0.7× 167 0.6× 253 1.3× 99 0.7× 167 1.4× 16 741
M R Stroud United States 13 786 1.4× 76 0.3× 178 0.9× 53 0.4× 219 1.8× 14 973

Countries citing papers authored by Charles Reichman

Since Specialization
Citations

This map shows the geographic impact of Charles Reichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Reichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Reichman more than expected).

Fields of papers citing papers by Charles Reichman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Reichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Reichman. The network helps show where Charles Reichman may publish in the future.

Co-authorship network of co-authors of Charles Reichman

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Reichman. A scholar is included among the top collaborators of Charles Reichman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Reichman. Charles Reichman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Badeti, Saiaditya, Alok Choudhary, Charles Reichman, et al.. (2021). CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro. Frontiers in Immunology. 12. 652223–652223. 33 indexed citations
2.
Calianese, David, Canan Kasikara, Viralkumar Davra, et al.. (2021). Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28–Stimulated T Cell IFN-γ and TNF-α Production. The Journal of Immunology. 207(2). 436–448. 2 indexed citations
3.
Sriram, Ganesh, Wojciech Jankowski, Canan Kasikara, et al.. (2014). Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk. Oncogene. 34(32). 4260–4269. 8 indexed citations
4.
Krachmarov, Chavdar, Kathy Revesz, Charles Reichman, et al.. (2012). Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals. Retrovirology. 9(S2). 6 indexed citations
5.
Sriram, Ganapathy, Charles Reichman, Naveen Kaushal, et al.. (2011). Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation. Oncogene. 30(46). 4645–4655. 21 indexed citations
6.
Sarkar, Paramita, Charles Reichman, Tamjeed Saleh, Raymond B. Birge, & Charalampos G. Kalodimos. (2007). Proline cis-trans Isomerization Controls Autoinhibition of a Signaling Protein. Molecular Cell. 25(3). 413–426. 161 indexed citations
7.
Reichman, Charles, et al.. (2007). Proapoptotic Function of the Nuclear Crk II Adaptor Protein. Biochemistry. 46(38). 10828–10840. 13 indexed citations
8.
Reichman, Charles, Kamalendra Singh, Yan Liu, et al.. (2005). Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain. Oncogene. 24(55). 8187–8199. 27 indexed citations
9.
Akakura, Shin, Sukhwinder Singh, Reiko Sanokawa‐Akakura, et al.. (2005). C‐terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac‐GEF. Journal of Cellular Physiology. 204(1). 344–351. 42 indexed citations
10.
Greulich, Heidi, Charles Reichman, & Hiroshi Hanafusa. (1996). Delay in serum stimulation of Erk activity caused by oncogenic transformation.. PubMed. 12(8). 1689–95. 16 indexed citations
11.
Birge, Raymond B., J. Eduardo Fajardo, Charles Reichman, et al.. (1993). Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.. Molecular and Cellular Biology. 13(8). 4648–4656. 234 indexed citations
12.
Birge, Raymond B., J. Eduardo Fajardo, Charles Reichman, et al.. (1993). Identification and Characterization of a High-Affinity Interaction Between v-Crk and Tyrosine-Phosphorylated Paxillin in CT10-Transformed Fibroblasts. Molecular and Cellular Biology. 13(8). 4648–4656. 64 indexed citations
13.
Matsuda, Michiyuki, Charles Reichman, & Hidesaburô Hanafusa. (1992). Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src. Journal of Virology. 66(1). 115–121. 29 indexed citations
14.
Reichman, Charles, Bruce J. Mayer, Satish Keshav, & Hidesaburô Hanafusa. (1992). The product of the cellular crk gene consists primarily of SH2 and SH3 regions.. PubMed. 3(7). 451–60. 137 indexed citations
15.
Hanafusa, Hidesaburô, Bruce J. Mayer, Charles Reichman, & Michinari Hamaguchi. (1990). Cell transformation by an oncogene that regulates protein kinases.. PubMed. 24. 280–3. 3 indexed citations
16.
Reichman, Charles. (1964). Advanced knitting principles. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026